Effect of gyejibongneyong-hwan for treatment of dysmenorrhea of uterine fibroids caused by blood stasis: A double blind, randomized placebo controlled trial
Not Applicable
Not yet recruiting
- Conditions
- Diseases of The genitoruinary system
- Registration Number
- KCT0001967
- Lead Sponsor
- Korea Institute of Oriental Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not yet recruiting
- Sex
- Female
- Target Recruitment
- 38
Inclusion Criteria
1.Females between 18 and 45 years of age and diagnosed with Blood stasis syndrome.
2.Females diagnosed blood stasis through screening test at gynecology
3.Confirmation of uterine myomas by ultrasonography (over 2 cm).
4.Provide written informed consent to participate in the study.
5.Agree to comply with the study regulations.
Exclusion Criteria
1. Patients with heart disease, liver disease, kidney disease or any psychiatric condition.
2. Patients who are unable to communicate or are critically ill.
3. Pregnant women.
5. Patients who take regular medication, including serotonin, anti-depressants, or other anti-psychiatric drugs.
4. Patients with any condition that could influence the study assessment.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umerical rating scale
- Secondary Outcome Measures
Name Time Method Screening question using blood stasis table;SFM-PQ;Dosage of analgesic ; Cox menstrual symptom scale;Size of myoma uteri